Natasha Akpoti-Uduaghan debunks issuing and apology to the Nigerian senate

  • Senator Natasha Akpoti-Uduaghan from Kogi Central has rejected allegations that she has issued an apology to the Nigerian Senate over the controversy that led to her suspension.
  • In a statement released on March 24, 2025, she described these claims as “false and misleading,”
  • the senator affirmed her commitment to her principles and the rights of her constituents, claiming that certain individuals are trying to manipulate public opinion with fabricated statements.
"I’ll continue to act as Senator as my suspension is illegal" – Natasha Akpoti

Senator Natasha Akpoti-Uduaghan of Kogi Central has denied reports that she has apologized to the Nigerian Senate concerning the issue that led to her suspension.

In a statement on March 24, 2025, she called these claims “false and misleading,” and reaffirmed her position regarding the six-month suspension.

She condemned those who are spreading this misinformation, accusing them of trying to misrepresent the truth and mislead the public.

Following a heated exchange with Senate leadership that resulted in her suspension, the senator asserted her commitment to her principles and the rights of her constituents, alleging that some people are trying to manipulate public perception with untrue statements.

“The reports suggesting that I have apologized to the Senate and retracted my position are completely untrue. I stand firmly by my words and actions and have not issued any apology to the Senate or anyone regarding this matter,” .

“I urge the public to disregard these rumours and publications as they do not represent my position. My commitment remains to truth, justice, and the people I represent.”

“This is not just about me; it is about the integrity of our democracy. I will not be intimidated or forced into submission through false narratives.”

“I appreciate the support and solidarity of my people. Rest assured, I will continue to fight for what is right and just.”

Be the first to comment

Leave a Reply